These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 24901647)
21. Arsenic trioxide and triptolide synergistically induce apoptosis in the SKM‑1 human myelodysplastic syndrome cell line. Hua HY; Gao HQ; Sun AN; Cen JN; Wu LL Mol Med Rep; 2016 Nov; 14(5):4180-4186. PubMed ID: 27665715 [TBL] [Abstract][Full Text] [Related]
22. Synergic effect of 3'-azido-3'-deoxythymidine and arsenic trioxide in suppressing hepatoma cells. Chen C; Zhang Y; Wang Y; Huang D; Xi Y; Qi Y Anticancer Drugs; 2011 Jun; 22(5):435-43. PubMed ID: 21502917 [TBL] [Abstract][Full Text] [Related]
23. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth. Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911 [TBL] [Abstract][Full Text] [Related]
24. Omega-3 and omega-6 polyunsaturated fatty acids enhance arsenic trioxide efficacy in arsenic trioxide-resistant leukemic and solid tumor cells. Wirtitsch M; Roth E; Bachleitner-Hofmann T; Wessner B; Sturlan S Oncol Res; 2009; 18(2-3):83-94. PubMed ID: 20066898 [TBL] [Abstract][Full Text] [Related]
25. Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level. Cheng B; Yang X; An L; Gao B; Liu X Auris Nasus Larynx; 2010 Feb; 37(1):89-94. PubMed ID: 19574005 [TBL] [Abstract][Full Text] [Related]
26. The roles of mitoferrin-2 in the process of arsenic trioxide-induced cell damage in human gliomas. Wang C; Chen X; Zou H; Chen X; Liu Y; Zhao S Eur J Med Res; 2014 Sep; 19(1):49. PubMed ID: 25256833 [TBL] [Abstract][Full Text] [Related]
27. Arsenic trioxide and promyelocytic leukemia protein-adenovirus synergistically inhibit in vitro and in vivo growth of a hepatoma cell line. Cui L; Zhang S; Zhang W; Hu Z; Cao Z; Li T Oncol Res; 2010; 18(7):305-14. PubMed ID: 20377131 [TBL] [Abstract][Full Text] [Related]
28. Arsenic trioxide exerts synergistic effects with cisplatin on non-small cell lung cancer cells via apoptosis induction. Li H; Zhu X; Zhang Y; Xiang J; Chen H J Exp Clin Cancer Res; 2009 Aug; 28(1):110. PubMed ID: 19664237 [TBL] [Abstract][Full Text] [Related]
29. Synergistic antitumor activity of oridonin and arsenic trioxide on hepatocellular carcinoma cells. Chen G; Wang K; Yang BY; Tang B; Chen JX; Hua ZC Int J Oncol; 2012 Jan; 40(1):139-47. PubMed ID: 21947421 [TBL] [Abstract][Full Text] [Related]
30. Carbonyl reductase 1 offers a novel therapeutic target to enhance leukemia treatment by arsenic trioxide. Jang M; Kim Y; Won H; Lim S; K R J; Dashdorj A; Min YH; Kim SY; Shokat KM; Ha J; Kim SS Cancer Res; 2012 Aug; 72(16):4214-24. PubMed ID: 22719067 [TBL] [Abstract][Full Text] [Related]
31. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. Xiao YF; Wu DD; Liu SX; Chen X; Ren LF World J Gastroenterol; 2007 Dec; 13(48):6498-505. PubMed ID: 18161919 [TBL] [Abstract][Full Text] [Related]
32. [Inhibitory effect of arsenic trioxide combined with cisplatin on human nasopharyngeal carcinoma xenograft and DAPK in nude mice]. Huang X; Wang X; Hu J; Zhou H; Zhou K; Zhang Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 May; 27(9):479-83. PubMed ID: 23898615 [TBL] [Abstract][Full Text] [Related]
33. Autophagy plays a pro-apoptotic role in arsenic trioxide-induced cell death of liver cancer. Deng ZT; Liang SF; Huang GK; Wang YQ; Tu XY; Zhang YN; Li S; Liu T; Cheng BB J Integr Med; 2024 May; 22(3):295-302. PubMed ID: 38599914 [TBL] [Abstract][Full Text] [Related]
34. The inhibition of growth and angiogenesis in heterotransplanted esophageal carcinoma via intratumoral injection of arsenic trioxide. Shen ZY; Shen J; Chen MH; Wu XY; Wu MH; Zeng Y Oncol Rep; 2003; 10(6):1869-74. PubMed ID: 14534710 [TBL] [Abstract][Full Text] [Related]
35. A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells. Wang W; Adachi M; Zhang R; Zhou J; Zhu D Pancreas; 2009 May; 38(4):e114-23. PubMed ID: 19342982 [TBL] [Abstract][Full Text] [Related]
36. Novel Combination of Arsenic Trioxide (As Yen CM; Tsai CW; Chang WS; Yang YC; Hung YW; Lee HT; Shen CC; Sheu ML; Wang JY; Gong CL; Cheng WY; Bau DT Cancer Genomics Proteomics; 2018; 15(6):453-460. PubMed ID: 30343279 [TBL] [Abstract][Full Text] [Related]
37. Antitumor efficacy of DMSA modified Fe3O4 magnetic nanoparticles combined with arsenic trioxide and adriamycin in Raji cells. Cai X; Cai X; Wang C; Chen B; Hua W; Shen F; Yu L; He Z; Shi Y; Chen Y; Xia G; Bao W; Zhang Y; Wang X J Biomed Nanotechnol; 2014 Feb; 10(2):251-61. PubMed ID: 24738333 [TBL] [Abstract][Full Text] [Related]
38. Neuroprotective effect of resveratrol on arsenic trioxide-induced oxidative stress in feline brain. Cheng Y; Xue J; Jiang H; Wang M; Gao L; Ma D; Zhang Z Hum Exp Toxicol; 2014 Jul; 33(7):737-47. PubMed ID: 24107457 [TBL] [Abstract][Full Text] [Related]
39. Arsenic trioxide induces apoptosis and inhibits the growth of human liver cancer cells. Sadaf N; Kumar N; Ali M; Ali V; Bimal S; Haque R Life Sci; 2018 Jul; 205():9-17. PubMed ID: 29738779 [TBL] [Abstract][Full Text] [Related]
40. Malignant cells can be sensitized to undergo growth inhibition and apoptosis by arsenic trioxide through modulation of the glutathione redox system. Dai J; Weinberg RS; Waxman S; Jing Y Blood; 1999 Jan; 93(1):268-77. PubMed ID: 9864170 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]